Summary
Adenosine deaminase (ADA) from a partially ADA-deficient Xhosa man has been characterized. This is only the second such case described in southern Africa, the previous one being a Kalahari San (“Bushman”). Red blood cell ADA levels were found to be only 6–9% of normal whereas his white cell ADA levels were much higher at 30% of normal. The stability of the enzyme at 57°C was shown to be greatly decreased indicating a mutation resulting in an enzyme with decreased stability in vivo. The Michaelis constant (Km) for adenosine was found to be normal. Deoxy-ATP levels in the red cells were elevated 2- to 3-times above normal, although this appears to be of no immunological consequence. Starch gel electrophoresis of red cell ADA from family members of the index case, in conjunction with red cell ADA activity levels, suggested that both parents carried a gene for partial ADA deficiency. Isoelectric focusing studies suggested that the two parental partial ADA-deficiency genes were not the same. Electrophoretic studies also revealed that another rare allele of ADA, possibly ADA*5, was segregating within the same family although this event appears to be unconnected with the ADA partial deficiency. A Xhosa population sample was assayed for red cell ADA activity. The results suggested a frequency of 0.015 ± 0.010 for ADA partial-deficiency alleles, although the number of different alleles involved is not known.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adrian GS, Wiginton DA, Hutton JJ (1984) Structure of adenosine deaminase mRNAs from normal and adenosine deaminase deficient lymphoblast cell lines. Mol Cell Biol 4:1712–1717
Beutler E (1975) Red cell metabolism. A manual of biochemical methods, 2nd edn. Grune & Stratton, New York San Francisco London
Borkowsky W, Gershon AA, Shenkman L, Hirschhorn R (1980) Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies. Pediatr Res 14:885–889
Coleman MS, Hutton JJ (1975) Micro-method for quantitation of adenosine deaminase activity in cells from human peripheral blood. Biochem Med 13:46–55
Conway EJ, Cooke R (1939)The deaminases of adenosine and adenylic acid in blood and tissues. Biochem J 33:479–492
Dadonna PE, Kelley WN (1981) Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts. Biochem Biophys Acta 658:280–290
Dadonna PE, Mitchell BS, Meuwissen HJ, Davidson BL, Wilson JM, Koller CA (1983) Adenosine deaminase deficiency with normal immune function — an acidic enzyme mutation. J Clin Invest 72:483–492
Dadonna PE, Davidson BL, Perignon JL, Kelley WN (1985) Genetic expression in partial adenosine deaminase deficiency. mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines. J Biol Chem 260:3875–3880
Detter JC, Stamatoyannopoulos G, Giblett ER, Motulsky AG (1970) Adenosine deaminase: racial distribution and report of a new phenotype. J Med Genet 7:356–357
Giblett ER, Anderson JW, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet II:1067–1069
Hirschhorn R (1983) Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy. In: Wedgewood RJ, Rosen FS, Paul MW (eds) Primary immunodeficiency diseases. (Birth Defects, vol 19) Liss, New York, pp 73–82
Hirschhorn R, Ellenbogen A (1986) Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency. Am J Hum Genet 38:13–25
Hirschhorn R, Ratech H (1983) Adenosine deaminase and its deficiency. Curr Top Hematol 4:1–35
Hirschhorn R, Roegner V, Jenkins T, Seaman C, Piomelli S, Borkowsky W (1979) Erythrocyte adenosine deaminase deficiency without immunodeficiency — evidence for an unstable mutant enzyme. J Clin Invest 64:1130–1139
Hirschhorn R, Martiniuk F, Roegner-Maniscalco V, Ellenbogen A, Perignon JL, Jenkins T (1983) Genetic heterogeneity in partial adenosine deaminase deficiency. J Clin Invest 71:1887–1892
Hopkinson DA, Cook PJL, Harris H (1969) Further data on the adenosine deaminase (ADA) polymorphism and a report of a new phenotype. Ann Hum Genet 32:361–367
Jenkins T (1973) Red cell adenosine deaminase deficiency in a healthy !Kung individual. Lancet II:736
Jenkins T, Rabson AR, Nurse GT, Lane AB, Hopkinson DA (1976) Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J Pediatr 89: 732–736
Jenkins T, Lane AB, Nurse GT, Hopkinson DA (1979) Red cell adenosine deaminase (ADA) polymorphism in southern Africa, with special reference to ADA deficiency among the !Kung. Ann Hum Genet 42425–433
Lowry OH, Rosebrough MJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Martin DW Jr, Gelfand EW (1981) Biochemistry of diseases of immunodevelopment. Annu Rev Biochem 50:845–877
Perignon J, Hamet M, Cartier P, Griscelli C (1979) Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and with primary hyperoxaluria in a 12-year-old boy. J Clin Chem Biochem 17:406
Renninger W, Bimboese C (1970) Genetics of red cell adenosine deaminase. Gene frequencies and family studies. Humangenetik 9:34–37
Schrader WP, Pollara B, Meuwissen HJ (1978) Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc Natl Acad Sci USA 75:446–450
Skoog WA, Beck WS (1956) Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood 11:436–454
Solter AW, Handschumacher RE (1969) A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA. Biochem Biophys Acta 174:585–590
Spencer M, Hopkinson DA, Harris H (1968) Adenosine deaminase polymorphism in man. Ann Hum Genet 32:9–14
Valerio D, Duyvestein MGC, van Ormondt H, Meera Khan P, van der Eb AJ (1984) Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein. Nucleic Acids Res 12:1015–1024
Van Laarhoven JPRM, de Bruyn CHMM (1983) Purine metabolism in relation to leukemia and lymphoid cell differentiation. Leuk Res 7:451–480
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hart, S.L., Lane, A.B. & Jenkins, T. Partial adenosine deaminase deficiency: another family from southern Africa. Hum Genet 74, 307–312 (1986). https://doi.org/10.1007/BF00282554
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00282554